Schedule 13G ownership disclosure
CLEARMIND MEDICINE INC
Common Shares, no par value per share · CUSIP: 185053402
Event date: 2025-12-03
- Filing-level shares
- 5,980,397.00
- Percent of class
- 9.97%
- Capitalink Ltd.
Shares: 5,980,397.00 · Class: 9.97%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001213900-25-120088
- Form type
- SCHEDULE 13G/A
- Filer
- Capitalink Ltd.
- CIK
- CIK 2036836
- Filed
- Dec 10, 2025
- Reporting period
- Dec 03, 2025
- Description
- Schedule 13G beneficial ownership